Nihon Medi Physics

Koto, Japan Founded: 1973 • Age: 53 yrs Acquired By GE Healthcare
Radiopharmaceuticals are developed for treating cancer and cardiovascular diseases.

About Nihon Medi Physics

Nihon Medi Physics is a Healthcare company based in Koto (Japan) founded in 1973, and was acquired by GE Healthcare in December 2024. Radiopharmaceuticals are developed for treating cancer and cardiovascular diseases. Its chief executive, as recorded, is Hisashi Shimoda. Its website nmp.co.jp draws about 32 thousand monthly visits. Its focus areas include Diversified Pharmaceuticals.

Company details

Nihon Medi Physics was founded in 1973 in Koto City, Japan, and operates within the radiopharmaceutical sector. Products are developed to address conditions such as cancer and cardiovascular diseases. The lead product, strontium chloride, is utilized for pain relief in cases of bone metastasis from cancer. Operations focus on research and production of these specialized treatments for medical applications.

  • Headquarters Koto, Japan
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website nmp.co.jp
  • Acquired by GE Healthcare (Dec 2024)
Key Metrics

Investors in Nihon Medi Physics

Nihon Medi Physics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GE Healthcare.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Materials management solutions are provided for healthcare organizations.
1892gehealthcare.comChicago, United States
Premium access

Investor details for Nihon Medi Physics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Nihon Medi Physics

1 people are tracked at Nihon Medi Physics (1 in leadership).

NameRoleGroup
Hisashi Shimoda
President & CEOLeadership
Premium access

Complete people profiles for Nihon Medi Physics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Nihon Medi Physics

2 dated milestones of Nihon Medi Physics across 51 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nihon Medi Physics is founded.
  2. Exit Acquired by GE Healthcare.

Web traffic of Nihon Medi Physics

The website of Nihon Medi Physics (nmp.co.jp) receives about 32.5K visits a month and ranks #832,745 among all websites worldwide, #996 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    32.5K

    ▼ 4.7% vs previous month

  • Unique visitors
    22.7K

    per month

  • Global rank
    #832,745

    among all websites

  • Category rank
    #996

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Nihon Medi Physics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
parkinson-smile.net
parkinson-smile.net
100%
#575,316–
pdradiopharma.com
pdradiopharma.com
81%
#2,231,158–
tmig.or.jp
tmig.or.jp
80%
#3,710,863–
yueki.com
yueki.com
79%
#3,005,900–
so-sho.jp
so-sho.jp
76%
#10,221,994–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Nihon Medi Physics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nihon Medi Physics

Premium access

Complete news archive for Nihon Medi Physics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nihon Medi Physics

Nihon Medi Physics was founded in 1973.

Nihon Medi Physics is headquartered in Koto, Japan. It is registered at Koto, Tokyo, Japan.

Hisashi Shimoda is the CEO of Nihon Medi Physics, as recorded in our data.

Nihon Medi Physics was founded in 1973 in Koto City, Japan, and operates within the radiopharmaceutical sector. Products are developed to address conditions such as cancer and cardiovascular diseases. The lead product, strontium chloride, is utilized for pain relief in cases of bone metastasis from cancer. Operations focus on research and production of these specialized treatments for medical applications.

Nihon Medi Physics has 1 investor. Key investors include GE Healthcare.

Yes. Nihon Medi Physics was acquired by GE Healthcare in December 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available